Arcturus Therapeutics, Inc.
Arcturus Therapeutics develops messenger RNA medicines for liver and respiratory rare diseases using LUNAR lipid-mediated delivery and STARR self-amplifying mRNA technology.
8-KNov 16Latest SEC filing
Nov 16Latest story
Arcturus Therapeutics develops messenger RNA medicines for liver and respiratory rare diseases using LUNAR lipid-mediated delivery and STARR self-amplifying mRNA technology.
November 2026
September 2026
August 2026
July 2026